New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
07:59 EDTESRX, ZGNXZogenix price target lowered to $2.50 from $5 at Oppenheimer
Oppenheimer cut its price target on Zogenix (ZGNX) after coverage of the company's Zohydro painkiller was terminated by Express Scripts (ESRX). However, the firm thinks recent disappointing news about Zogenix is already reflected in the stock. Oppenheimer keeps an Outperform rating on the shares.
News For ZGNX;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
07:36 EDTESRXExpress Scripts price target raised to $90 from $85 at Leerink
Subscribe for More Information
February 25, 2015
10:11 EDTESRXExpress Scripts says willing to do 'tranformational' deal
Subscribe for More Information
February 24, 2015
13:23 EDTESRXLeerink healthcare technology analyst holds analyst/industry conference call
Healthcare Tech & Distribution Analyst Larsen discusses th 2016 Pharmacy Benefits Management (PBM) selling season, the impact of the Hep C PBM formulary negotiations on the selling season and specialty drug trend and areas of opportunity for PBMs on an Analyst/Industry conference call to be held on March 5 at 2 pm.
February 23, 2015
18:02 EDTESRXOn The Fly: After Hours Movers
Subscribe for More Information
16:04 EDTESRXExpress Scripts sees Q1 EPS $1.07-$1.11, consensus $1.16
Subscribe for More Information
16:03 EDTESRXExpress Scripts sees FY15 EPS $5.35-$5.49, consensus $5.44
Subscribe for More Information
16:02 EDTESRXExpress Scripts reports Q4 EPS 1.39, consensus $1.38
Subscribe for More Information
15:23 EDTESRXNotable companies reporting after market close
Subscribe for More Information
06:28 EDTESRXExpress Scripts weekly volatility elevated into Q4 and outlook
Subscribe for More Information
February 18, 2015
05:36 EDTESRXExpress Scripts to host investor meeting
Investor meeting to be held in St. Louis on February 25 at 8:30 am. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use